AnalystsKeay NakaeKeay Nakae's Stock Forecasts
AnalystsKeay Nakae
Analyst Ranking
Top 1%
#38 out of 4053 analysts
Average Return
+60.95%
Win Rate
29%19 out of 65
Risk vs Reward
Poor
Good
Keay Nakae's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Ocugen IncOCGN | +5,554.71% | $0.22 | $12.61 | 2020-06-02 - 2021-02-09 | Strong Buy |
Carecloud IncMTBC | +104.17% | $2.40 | $4.90 | 2017-11-13 - 2018-11-14 | Strong Buy |
Dicerna Pharmaceuticals IncDRNA | +70.89% | $22.19 | $37.92 | 2021-08-09 - 2021-12-09 | Strong Buy |
Mesoblast LtdMESO | +67.64% | $16.10 | $5.21 | 2020-12-03 - 2021-12-03 | Strong Sell |
Arrowhead Pharmaceuticals IncARWR | +62.51% | $19.39 | $31.51 | 2018-09-05 - 2019-09-06 | Strong Buy |
Keay Nakae's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Avidity Biosciences IncRNA | 2 | Strong Buy | $27.00 | +64.03% | Maintains | 10 days ago |
Omega Therapeutics IncOMGA | 1 | Strong Buy | $12.00 | +125.56% | Initiates Coverage On | 14 days ago |
Exicure IncXCUR | 3 | Hold | $2.00 | +11.11% | Maintains | 2 months ago |
Sonnet Biotherapeutics Holdings IncSONN | 4 | Strong Buy | $2.00 | +29.03% | Maintains | 2 months ago |
Evelo Biosciences IncEVLO | 2 | Strong Buy | $5.00 | +112.77% | Maintains | 2 months ago |
Pear Therapeutics IncPEAR | 3 | Strong Buy | $9.00 | +284.62% | Maintains | 2 months ago |
Neubase Therapeutics IncNBSE | 4 | Strong Buy | $7.00 | +1,952.79% | Maintains | 2 months ago |
Proqr Therapeutics NvPRQR | 5 | Hold | N/A | N/A | Downgrades | 2 months ago |
Sab Biotherapeutics IncSABS | 4 | Strong Buy | $3.00 | +240.91% | Maintains | 2 months ago |
Alnylam Pharmaceuticals IncALNY | 2 | Strong Buy | $250.00 | +23.54% | Maintains | 2 months ago |
Better Therapeutics IncBTTX | 3 | Strong Buy | $17.00 | +877.01% | Maintains | 2 months ago |
Dyne Therapeutics IncDYN | 1 | Strong Buy | $17.00 | +28.01% | Initiates Coverage On | 3 months ago |
4d Pharma PLCLBPS | 1 | Hold | N/A | N/A | Downgrades | 3 months ago |
Mesoblast LtdMESO | 3 | Strong Sell | $2.50 | -16.39% | Maintains | 4 months ago |
Biomx IncPHGE | 3 | Strong Buy | $6.00 | +1,392.54% | Maintains | 4 months ago |
Axcella Health IncAXLA | 3 | Strong Buy | $7.00 | +293.26% | Maintains | 5 months ago |
Emergent Biosolutions IncEBS | 7 | Strong Buy | $65.00 | +214.31% | Maintains | 5 months ago |
Kaleido Biosciences IncKLDO | 3 | Hold | $1.70 | +1,033.33% | Downgrades | 6 months ago |
Silence Therapeutics PLCSLN | 1 | Strong Buy | $33.00 | +230.00% | Initiates Coverage On | 6 months ago |
Femasys IncFEMY | 2 | Strong Buy | $18.00 | +1,425.42% | Maintains | 6 months ago |
Arbutus Biopharma CorpABUS | 2 | Strong Buy | $6.00 | +201.51% | Maintains | 7 months ago |
Dicerna Pharmaceuticals IncDRNA | 3 | Hold | $38.25 | +0.08% | Downgrades | 10 months ago |
Forte Biosciences IncFBRX | 2 | Hold | $3.50 | N/A | Upgrades | a year ago |
Arrowhead Pharmaceuticals IncARWR | 3 | Strong Buy | $94.00 | N/A | Maintains | a year ago |
Seres Therapeutics IncMCRB | 1 | Strong Buy | $16.00 | N/A | Maintains | a year ago |
Ocugen IncOCGN | 2 | Hold | $13.00 | N/A | Downgrades | 2 years ago |
Oncocyte CorpOCX | 2 | Hold | $2.00 | N/A | Downgrades | 2 years ago |
Lisata Therapeutics IncLSTA | 1 | Strong Buy | $7.00 | N/A | Maintains | 5 years ago |
Carecloud IncMTBC | 1 | Strong Buy | $2.75 | N/A | Maintains | 5 years ago |
Biocept IncBIOC | 1 | Strong Buy | $2.50 | N/A | Initiates Coverage On | 5 years ago |
©2022 WallStreetZen
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.